Sequoia China Leads $240M Round In Genomic Big Data Platform WuXi NextCODE

WuXi NextCODE, a genomic big data platform resulted from a merger between Chinese contract research outsourcing provider WuXi AppTec’s genome center and NextCODE, has raised a US$240 million series B financing led by Sequoia Capital China. The round is among the largest venture financing deals for a start-up in the healthcare sector in China.

WuXi NextCODE Raises $75M Round Led By Temasek And Yunfeng Capital

WuXi NextCODE, a contract genomics organization and a unit under Wuxi AppTec, has closed a US$75 million series B financing co-led by Temasek Holdings and Yunfeng Capital. Other investors, including Amgen Ventures, a corporate venture capital fund established by Amgen Inc., and 3W Partners, a Greater China and cross-border focused private equity firm, also participated in the round. "We are building the world’s leading genomic data platform, applying genome sequencing data at scale to improve human health and wellness around …